Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.
Perkins BA, Jonsdottir K, Briem H, Griffiths E, Plikaytis BD, Hoiby EA, Rosenqvist E, Holst J, Nokleby H, Sotolongo F, Sierra G, Campa HC, Carlone GM, Williams D, Dykes J, Kapczynski D, Tikhomirov E, Wenger JD, Broome CV.
Perkins BA, et al.
J Infect Dis. 1998 Mar;177(3):683-91. doi: 10.1086/514232.
J Infect Dis. 1998.
PMID: 9498448
Clinical Trial.